LUPINNSELupin Limited· PharmaceuticalsLowNeutral
Announced Sat, 19 Jul · 21:14 IST

Lupin Limited has informed the Exchange regarding ''Business Responsibility and Sustainability Report for F.Y. 2024-25'.

LUPIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lupin has submitted its annual Business Responsibility and Sustainability Report (BRSR) for FY 2024-25 to the stock exchanges, as required by SEBI regulations. This is part of the company's Integrated Report covering the standalone entity and has been independently assured by DNV Business Assurance (Reasonable Assurance for Core Indicators). Key highlights: standalone turnover of ₹164,585.8 million with exports contributing 53.9%, net worth of ₹243,079.1 million, a workforce of 19,897 employees and 1,795 workers across 12 national and 3 international plants. On ESG progress, Lupin reports a 23% reduction in Scope 1 and 2 emissions versus FY23 baseline, 19% renewable electricity usage, and 9% women in its workforce (target 15% by 2030). The company spent ₹17,672 million on R&D and ₹528 million on sustainability-focused capex in FY25. One worker fatality was recorded during the year, and customer complaints rose to 34,802 from 33,502 the previous year.

Likely market impact

This is a routine regulatory ESG disclosure rather than a new business event, so it is unlikely to move the stock on its own. Investors can use the report to track Lupin's progress on long-term sustainability targets (emissions reduction, gender diversity, renewable energy) and operational metrics like exports and R&D intensity.